Skip to main content
. 2020 Oct 23;9(24):9365–9372. doi: 10.1002/cam4.3552

FIGURE 3.

FIGURE 3

Association of clinical outcome with DDR among patients who received PD‐1/PD‐L1 inhibitors. 3A: OS based on presence or absence of DDR alterations; 3B: OS based on number of DDR alterations; 3C: OS based on presence or absence of ATM alterations; 3D: Tumor mutational burden based on DDR status